1 Min Read
March 31 (Reuters) - JCR Pharmaceuticals Co Ltd :
* Says co initiates phase 1/2 clinical trial of jr-141 in hunter syndrome
Source text in Japanese: goo.gl/axW7jJ
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.